Sponsor or institution

Clinical trials and research at Ankyra Therapeutics, Inc

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Tolododekin alfa (ANK-101) plus anti-PD-1/PD-L1 antibody for advanced non-small cell lung cancer

  This trial will try tolododekin alfa (ANK-101) together with an anti-PD-1/PD-L1 antibody in people with advanced or metastatic non-small cell lung cancer, with one group previously treated with PD-1/PD-L1 plus platinum chemotherapy and another group who are treatment-naïve.

  Recruiting at 10 sites Phase 1 Ankyra Therapeutics, Inc · Coral Gables, Florida and 10 other locations · NCT07027514

• Testing a new treatment for advanced solid tumors

  This study is testing a new treatment called tolododekin alfa for people with advanced solid tumors that haven't improved with standard therapies to see how safe it is and how well it works.

  Recruiting at 5 sites Phase 1 Ankyra Therapeutics, Inc · Bethesda, Maryland and 4 other locations · NCT06171750

Quick answers

How many clinical trials run by Ankyra Therapeutics, Inc are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →